Navigation Links
CHF International Named Global Fund Principal Recipient in Honduras
Date:11/20/2007

SILVER SPRING, Md., Nov. 20 /PRNewswire-USNewswire/ -- CHF International has been selected as the Global Fund to Fight AIDS, Tuberculosis and Malaria's (Global Fund) new Principal Recipient (PR) for HIV/AIDS prevention, treatment and care in Honduras--the only country in Latin America awarded an HIV proposal in Round 3 programming.

As a PR, over the next six years, CHF will be directly responsible for managing Honduras' US$47 million in HIV-focused resources for the Global Fund, including program development, technical support, volunteer and community mobilization, pharmaceutical procurement and monitoring and evaluation. CHF International will directly sub-grant the Global Fund resources to the Honduran government and civil society organizations fighting the epidemic, while building their capacity to provide sustainable, high-quality services.

"After 20 continuous years of working in Honduras, we are extremely pleased to have the opportunity to help the country develop the sustainable systems and technical capacity needed for them to effectively respond to the HIV/AIDS epidemic on their own," said Randy Lyness, CHF International's Regional Director for Latin America and the Caribbean.

For five years, CHF International successfully managed the Sustainable Improvements to Family Health Program, a partnership of CHF, the U.S. Agency for International Development, the Honduras Ministry of Health and the National Water and Sewer Authority. The program provided grant funds to 43 government health program implementers to improve reproductive heath and child survival, infectious disease, health reform, and the prevention of HIV/AIDS and other sexually-transmitted infections.

Guided by CHF International's community-based approach, one of the organization's key efforts will be working at grassroots levels with community members and volunteers so that they can more effectively sustain their efforts in HIV education, prevention, treatment and care. The effort will proactively work to strengthen the country's monitoring and evaluation frameworks, will guarantee the performance of local implementers, and will ensure the timely and efficient delivery of pharmaceuticals along the supply chain.

Honduras's HIV epidemic is largely due to sexual transmission, with the highest prevalence among commercial sex workers, men who have sex with men and prisoners. As the Principal Recipient of the Global Fund award, CHF will be fully supportive of Honduras' goals of reducing disease prevalence to less than 1 percent, improving the survival of people living with HIV/AIDS who are on antiretroviral treatment to 95 percent, and reducing mother to child transmission by 90 percent by 2013.

The Global Fund was created to finance a dramatic turn-around in the fight against AIDS, tuberculosis and malaria. These diseases kill over 6 million people each year, and the numbers are growing. As a partnership between governments, civil society, the private sector and affected communities, the Global Fund represents an innovative approach to international health financing. To date, the Global Fund has committed US$ 9.9 billion in 136 countries to support aggressive interventions against all three diseases.

Founded in 1952, CHF International's mission is to be a catalyst for long-lasting positive change in low- and moderate-income communities around the world, helping them to improve their social, economic and environmental conditions. The organization provides technical expertise and leadership in international development, including critical emergency management following disasters and civil conflict. CHF International has worked in over 100 countries worldwide since its inception. Visit http://www.chfinternational.org for more information about the organization.


'/>"/>
SOURCE CHF International
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
(Date:6/23/2016)... June 23, 2016 Research and ... Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, ... report to their offering. ... for healthcare business planners, provides surgical procedure volume data ... trends with an in-depth analysis of growth drivers and ...
Breaking Medicine Technology: